Filing Details
- Accession Number:
- 0000711377-19-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-24 18:09:53
- Reporting Period:
- 2019-01-22
- Accepted Time:
- 2019-01-24 18:09:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1168789 | L James Herbert | Neogen Corp 620 Lesher Place Lansing MI 48912 | Yes | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-01-22 | 25,334 | $40.46 | 761,818 | No | 4 | M | Direct | |
Coommon Stock | Disposition | 2019-01-22 | 25,334 | $60.01 | 736,484 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-01-22 | 10,000 | $60.24 | 726,484 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-01-22 | 10,000 | $60.00 | 403,035 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock (right to Buy) | Disposition | 2019-01-22 | 25,334 | $0.00 | 25,334 | $40.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
276,767 | 2021-10-29 | No | 4 | M | Direct |
Footnotes
- Options were granted 9/29/2016, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
- These shares were sold out of a charitable remainder trust in which Mr. Herbert and his spouse are beneficiaries and trustees; 98,783 shares remain in the trust. An additional 144,280 shares are held in trust for Mr. Herbert's spouse. The remaining shares are held in limited liability companies in which Mr. Herbert and his spouse have minority financial position.